Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsCytomegalovirus InfectionsRoseolovirus InfectionsAspergillosisHistocompatibility TestingStem CellsBone Marrow TransplantationTreatment OutcomeCytomegalovirusFetal BloodRetrospective StudiesTissue DonorsPeripheral Blood Stem Cell TransplantationGraft SurvivalHematopoietic Stem CellsTransplantation ChimeraImmunosuppressive AgentsRecurrenceBusulfanGraft vs Leukemia EffectTransplantationRemission InductionMyeloablative AgonistsLeukemiaImmunocompromised HostVidarabineHistocompatibilityKidney TransplantationGraft vs Tumor EffectTime FactorsWhole-Body IrradiationBlood Transfusion, AutologousCombined Modality TherapyMultiple MyelomaGraft RejectionT-LymphocytesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSalvage TherapyAntigens, CD34Survival AnalysisHematopoietic Stem Cell MobilizationOpportunistic InfectionsLymphocyte DepletionTransplantsSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaEmbryonic Stem CellsSpinal CordMycosesVirus ActivationAdult Stem CellsSiblingsImmunosuppressionAcute DiseaseAnemia, AplasticMyelodysplastic SyndromesHematologic DiseasesHepatic Veno-Occlusive DiseaseHLA AntigensChimerismAntineoplastic Combined Chemotherapy ProtocolsAntilymphocyte SerumCyclophosphamideFollow-Up StudiesCell DifferentiationMelphalanCells, CulturedDisease-Free SurvivalLymphocyte TransfusionCyclosporineMinor Histocompatibility AntigensGanciclovirFlow CytometryTransplantation ImmunologyHerpesvirus 6, HumanPluripotent Stem CellsLeukocyte TransfusionFatal OutcomeLymphoproliferative DisordersNeoplasm, ResidualBone Marrow CellsAntiviral AgentsLymphocyte Culture Test, MixedPrognosisRisk FactorsSpinal Cord InjuriesProspective StudiesMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorCell SeparationHodgkin DiseaseLeukemia, Myeloid